In: PATENT NEWS
Law360, New York (January 31, 2018, 12:19 PM EST) — The last few days of a patent are often its most valuable. Maximizing patent term is therefore a chief goal for many patent applicants. The need to file a terminal disclaimer in order to obviate obviousness-type double patenting, however, may... Continue reading
In: PATENT NEWS
As I said, it’s a complex issue, involving treaty arrangements, patent law, and much more, rooted ultimately in the socialized medical systems we find abroad, toward which, alas, we ourselves are moving. In fact, the ultimate aim of many of the reimportation proponents is to have the federal government …
In: PATENT NEWS
Soryn IP Group Closes $140 Million In Patent Deals In 2017 PR Newswire (press release) Full coverage
In: PATENT NEWS
Nanotech Granted New KolourOptik Patent in China GlobeNewswire (press release) Full coverage
In: PATENT NEWS
BRIEF-EyeGene receives patent Reuters Full coverage
In: COPYRIGHT NEWS
We Shall Overcome is public domain in the US after copyright case settled Complete Music Update ‘We Shall Overcome’ becomes public domain in copyright settlement UPI.com Full coverage
In: PATENT NEWS
Ford has filed a patent for an autonomous Robocop police car, which aims to catch traffic law violators. Ford’s autonomous police car will use machine learning tools to take action and catch those who break the speed limit or run red lights and issue tickets remotely. Taking in information, the... Continue reading
In: PATENT NEWS
As reported in our prior blog post, the Federal Circuit appears poised to decide whether a corporation can be sued for patent infringement in any federal district in its state of incorporation. In a recent order in the Central District of California case of Realtime Data LLC v. Nexenta Systems,... Continue reading
In: PATENT NEWS
Law360, Los Angeles (January 30, 2018, 6:23 PM EST) — Nixon Peabody LLP has added two patent litigation partners from litigation and trials boutique LTL Attorneys LLP in Los Angeles, bolstering the firm’s growing West Coast intellectual property reach for technology clients in the United States and …
In: PATENT NEWS
Three pharmaceutical companies on Tuesday added another patent to an infringement suit against Sandoz Inc., as it tries to prevent a contingent of drugmakers from bringing generic versions of the gastrointestinal drug Linzess to market. In an eight-page complaint, Allergan USA, Forest Laboratories …
Designed by Industrial Action
Copyright © 2024 OPUS IP Limited. All Rights Reserved
OPUS IP Limited: COMPANY & OTHER LEGAL INFORMATION